Huntington National Bank’s bluebird bio BLUE Stock Holding History

Huntington National Bank’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,460	Closed	-$35.9K	–	4168
2024 Q3	$35.9K	Buy	3,460 +35	+1%	+$582	﹤0.01%	1304
2024 Q2	$67.4K	Hold	3,425	–	–	﹤0.01%	987
2024 Q1	$87.7K	Buy	3,425 +3,400	+13,600%	+$87.1K	﹤0.01%	933
2023 Q4	$690	Buy	+25	New	+$1.52K	﹤0.01%	2268
2023 Q3	–	Sell	-6	Closed	-$408	–	3845
2023 Q2	$408	Buy	+6	New	+$439	﹤0.01%	2240
2020 Q1	–	Sell	-6	Closed	-$7K	–	1545
2019 Q4	$7K	Buy	+6	New	+$6.52K	﹤0.01%	1455
2018 Q3	–	Sell	-28	Closed	-$57K	–	1676
2018 Q2	$57K	Hold	28	–	–	﹤0.01%	890
2018 Q1	$61K	Hold	28	–	–	﹤0.01%	902
2017 Q4	$64K	Hold	28	–	–	﹤0.01%	908
2017 Q3	$49K	Hold	28	–	–	﹤0.01%	986
2017 Q2	$38K	Buy	+28	New	+$33.8K	﹤0.01%	1012
2016 Q1	–	Sell	-12	Closed	-$10K	–	1725
2015 Q4	$10K	Buy	+12	New	+$12K	﹤0.01%	1356

Other funds holding BLUE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Huntington National Bank's BLUE Position: Q4 2024 in Review

Huntington National Bank sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 3,460 shares — an estimated $35.9K sold.

Huntington National Bank first reported a position in BLUE in Q4 2015 and held it in 12 quarters. The position peaked at $87.7K in Q1 2024. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

Huntington National Bank reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
Huntington National Bank sold 3,460 bluebird bio shares in Q4 2024, an estimated $35.9K.
Huntington National Bank first reported a position in bluebird bio in Q4 2015 and held it in 12 quarters.
Huntington National Bank's bluebird bio position peaked at $87.7K in Q1 2024.
83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Huntington National Bank's 13F filing for Q4 2024, filed 12 Feb 2025.